Mahesh Karande - 01 Feb 2022 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role: President and CEO, Director
Signature: /s/ Barbara Chan as Attorney-in-Fact for Mahesh Karande
Issuer symbol: OMGAQ
Transactions as of: 01 Feb 2022
Net transactions value: +$5,989
Form type: 4
Filing time: 03 Feb 2022, 15:05:20 UTC
Previous filing: 29 Jul 2021
Next filing: 11 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OMGA	Common Stock	Options Exercise	$5,989	+11,300	+11%	$0.5300^*	117,711	01 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OMGA	Option (Right to Buy)	Options Exercise	$0	-11,300	-1.3%	$0.000000	884,071	01 Feb 2022	Common Stock	11,300	$0.5300	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest and become exercisable with respect to 25% of the underlying shares on April 1, 2020 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on April 1, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.